Table 3.
Parameter | FOS treatment % | |||||
---|---|---|---|---|---|---|
Control | 0.3 | 0.5 | 0.7 | SEM | P -value | |
Serum | ||||||
TAC (mmol/l) | 0.39a | 0.9b | 1.01b | 0.5c | 0.02 | 0.015 |
MDA (nmol/ml) | 5.12a | 2.1b | 2.5b | 3.8c | 0.04 | 0.025 |
Liver | ||||||
TSOD (U/mg pro.) | 3.99 | 4.0 | 4.0 | 4.1 | 0.45 | 0.452 |
GPx (U/mg pro.) | 0.68 | 0.60 | 0.70 | 0.70 | 0.09 | 0.847 |
CAT (k/mg pro.) | 0.30a | 0.30a | 0.80b | 0.70b | 0.02 | 0.001 |
MDA (nmol/mg pro.) | 8.01a | 3.7b | 7.1c | 5.01d | 0.11 | 0.031 |
FOS, Fructo-oligosaccharides. All treatment groups received a soybean basal diet. Differences between the treatment groups are statistically different at P < 0.05, TAC, Total Antioxidant Capacity; MDA, Malondialdehyde; TSOD, Total Superoxide Dismutase; GPx, Liver Glutathione Peroxidase; CAT, Catalase enzyme. Mean values within the same raw with different superscript letters are significantly different.